Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-22
2011-11-01
Jarrell, Noble (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S553000
Reexamination Certificate
active
08048877
ABSTRACT:
This invention relates to novel guanidine derivatives useful as modulators of small-conductance calcium-activated potassium channels (SK channels). In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
REFERENCES:
patent: 4369325 (1983-01-01), Toldy et al.
patent: 5604228 (1997-02-01), Keana et al.
patent: 6194447 (2001-02-01), Jensen et al.
patent: 7067507 (2006-06-01), Pulley et al.
patent: 869181 (1961-05-01), None
patent: WO-95/20950 (1995-08-01), None
Jantzen and Robinson. Modern Pharmaceutics, 1996, p. 596.
Sailer et al., Mol. Cell. Neurosci. 2004 26 pp. 458-469.
Liegeois J-F et al., Current Medicinal Chemistry 2003, 10, pp. 625-647.
Struve et al., J. Org. Chem. 1977 42 (25) p. 4035-4040.
Christophersen Palle
Eriksen Birgitte L.
Johansen Tina Holm
Peters Dan
Strøbæk Dorte
Birch & Stewart Kolasch & Birch, LLP
Jarrell Noble
Neurosearch A/S
LandOfFree
Guanidine derivatives and their medical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine derivatives and their medical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine derivatives and their medical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4276193